Ramsay Générale de Santé
ISIN
FR0000044471
Ticker
GDS
Sector
Sub-Industry
Country
France
Year Founded
1987
ISIN
FR0000044471
Ticker
GDS
Sector
Sub-Industry
Country
France
Year Founded
1987
In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three areas: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the healthcare network of the country, as in Sweden, where the group has more than a hundred local healthcare centers.
The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, particularly in outpatient surgery and improved recovery after surgery.
The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernization of establishments. It also innovates in the service of patients with new digital tools and by developing its organizations to improve the efficiency of care.
36,000
Europe
| Line item in (eur) | 01.07.2020 | 01.07.2021 | 01.07.2022 |
|---|---|---|---|
| Assets | N/A | 6,681,700,000.00 | 6,787,900,000.00 |
| Noncurrent Assets | N/A | 5,212,900,000.00 | 5,532,500,000.00 |
| Property Plant And Equipment | N/A | 918,000,000.00 | 950,200,000.00 |
| Goodwill | N/A | 1,762,600,000.00 | 2,065,100,000.00 |
| Intangible Assets Other Than Goodwill | N/A | 241,200,000.00 | 244,700,000.00 |
| Investment Accounted For Using Equity Method | N/A | 300,000.00 | 200,000.00 |
| Deferred Tax Assets | N/A | 125,400,000.00 | 94,700,000.00 |
| Other Noncurrent Financial Assets | N/A | 85,600,000.00 | 119,400,000.00 |
| Current Assets | N/A | 1,468,800,000.00 | 1,255,400,000.00 |
| Inventories | N/A | 111,400,000.00 | 111,200,000.00 |
| Current Trade Receivables | N/A | 323,400,000.00 | 422,000,000.00 |
| Current Tax Assets Current | N/A | 7,600,000.00 | 4,700,000.00 |
| Cash and cash equivalents | 538,300,000.00 | 608,400,000.00 | 132,500,000.00 |
| Other Current Assets | N/A | 406,400,000.00 | 574,000,000.00 |
| Equity And Liabilities | N/A | 6,681,700,000.00 | 6,787,900,000.00 |
| Equity | 1,037,200,000.00 | 1,098,700,000.00 | 1,238,700,000.00 |
| Issued Capital | N/A | 82,700,000.00 | 82,700,000.00 |
| Retained Earnings Profit Loss For Reporting Period | N/A | 65,000,000.00 | 118,400,000.00 |
| Share Premium | N/A | 611,200,000.00 | 611,200,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 1,070,300,000.00 | 1,212,400,000.00 |
| Noncontrolling Interests | N/A | 28,400,000.00 | 26,300,000.00 |
| Noncurrent Liabilities | N/A | 4,032,100,000.00 | 4,063,800,000.00 |
| Noncurrent Provisions For Employee Benefits | N/A | 157,600,000.00 | 115,700,000.00 |
| Other Longterm Provisions | N/A | 176,900,000.00 | 164,700,000.00 |
| Deferred Tax Liabilities | N/A | 51,200,000.00 | 39,700,000.00 |
| Other Noncurrent Liabilities | N/A | 32,600,000.00 | 8,900,000.00 |
| Longterm Borrowings | N/A | 1,673,600,000.00 | 1,763,600,000.00 |
| Current Liabilities | N/A | 1,550,900,000.00 | 1,485,400,000.00 |
| Current Provisions | N/A | 51,700,000.00 | 48,400,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 343,800,000.00 | 410,800,000.00 |
| Current Tax Liabilities Current | N/A | 16,600,000.00 | 19,200,000.00 |
| Other Current Liabilities | N/A | 901,800,000.00 | 775,600,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 38,100,000.00 | 35,400,000.00 |
| Line item in (eur) | 01.07.2020/ 01.07.2021 |
01.07.2021/ 01.07.2022 |
|---|---|---|
| Revenue | 4,022,600,000.00 | 4,301,000,000.00 |
| Interest Income On Cash And Cash Equivalents | 800,000.00 | 600,000.00 |
| Raw Materials And Consumables Used | 818,600,000.00 | 890,700,000.00 |
| Employee Benefits Expense | 2,115,700,000.00 | 2,244,100,000.00 |
| Depreciation And Amortisation Expense | 371,800,000.00 | 377,300,000.00 |
| Tax Expense Other Than Income Tax Expense | 131,800,000.00 | 129,600,000.00 |
| Profit Loss From Operating Activities | 250,600,000.00 | 291,300,000.00 |
| Income Tax Expense Continuing Operations | 29,500,000.00 | 57,300,000.00 |
| Profit (loss) | 73,800,000.00 | 127,800,000.00 |
| Profit Loss Attributable To Owners Of Parent | 65,000,000.00 | 118,400,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 8,800,000.00 | 9,400,000.00 |
| Line item in (eur) | 01.07.2020 | 01.07.2021 | 01.07.2022 |
|---|---|---|---|
| Profit (loss) | N/A | 73,800,000.00 | 127,800,000.00 |
| Adjustments For Income Tax Expense | N/A | 29,500,000.00 | 57,300,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 371,800,000.00 | 377,300,000.00 |
| Other Adjustments For Noncash Items | N/A | 7,900,000.00 | 3,400,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 21,200,000.00 | 41,700,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 652,300,000.00 | 262,500,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 65,500,000.00 | 1,000,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 73,600,000.00 | 297,400,000.00 |
| Dividends Received Classified As Investing Activities | N/A | 600,000.00 | 700,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -181,400,000.00 | -471,100,000.00 |
| Proceeds From Issuing Shares | N/A | 0.00 | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 1,560,300,000.00 | 200,000,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 1,622,500,000.00 | 112,400,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 191,000,000.00 | 212,600,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -390,600,000.00 | -264,200,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -10,200,000.00 | -3,100,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 80,300,000.00 | -472,800,000.00 |
| Cash and cash equivalents | 538,300,000.00 | 608,400,000.00 | 132,500,000.00 |
Please note that some sums might not add up.
FR0000044471
969500I1EJGUAT223F44
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.